Hyperinsulinaemia is Not a Major Coronary Risk Factor in Elderly Men. The Study of Men Born in 1913

Overview

Journal Diabetologia

Specialty Endocrinology

Date 1992 Aug 1

PMID 1511804

Citations 18

Authors

L Welin

H Eriksson

B Larsson

L O Ohlson

K Svardsudd

G Tibblin

Affiliations

Soon will be listed here.

Abstract

Insulin and insulin resistance have attracted considerable interest as possible risk factors for coronary heart disease during the last decade. We therefore examined the 8-year incidence of coronary heart disease in 595 67-year-old men in relation to baseline insulin and other risk factors. The incidence of coronary heart disease increased from 9% among non-diabetic men to 13.5% among those with impaired glucose tolerance, 12.9% among newly-detected diabetic men and up to 31.3% among men with known diabetes. The incidence of coronary heart disease was related to fasting blood glucose and 1 h and 2 h blood glucose during the oral glucose tolerance test and to serum cholesterol and serum triglycerides. Fasting serum insulin was of borderline significance for the risk of coronary heart disease. When known diabetic subjects were excluded only serum cholesterol and serum triglycerides remained as statistically significant risk factors. Among diabetic subjects (known and newly-detected) only blood glucose was related to the risk of coronary heart disease. In multivariate analyses the different degrees of glucose intolerance or fasting blood glucose were independently related to the risk of coronary heart disease (p = 0.008-0.010). Serum triglycerides were also an independent risk factor in three out of four multivariate models (p = 0.02-0.09). Fasting serum insulin was not an independent risk factor. These findings do not support the hypothesis that hyperinsulinaemia is a major risk factor for coronary heart disease in elderly men. Hyperglycaemia (or diabetes mellitus) seems to be the most important risk factor.

Citing Articles

The Epidemiological Boehringer Ingelheim Employee Study (Part 3): Association of Elevated Fasting Insulin Levels but Not HOMA-IR With Increased Intima Media Thickness and Arteriosclerosis in Middle-Aged Persons.

Rohling M, Kempf K, Kolb H, Martin T, Schneider M, Martin S Front Cardiovasc Med. 2021; 8:752789.

PMID: 34746266 PMC: 8569239. DOI: 10.3389/fcvm.2021.752789.

Fasting insulin concentrations and incidence of hypertension, stroke, and coronary heart disease: a meta-analysis of prospective cohort studies.

Xun P, Wu Y, He Q, He K Am J Clin Nutr. 2013; 98(6):1543-54.

PMID: 24132974 PMC: 3831539. DOI: 10.3945/ajcn.113.065565.

Insulin and cardiovascular disease: biomarker or association?.

Jandeleit-Dahm K, Gray S Diabetologia. 2012; 55(12):3145-51.

PMID: 23052054 DOI: 10.1007/s00125-012-2729-4.

Effect of pre-diabetes on future risk of stroke: meta-analysis.

Lee M, Saver J, Hong K, Song S, Chang K, Ovbiagele B BMJ. 2012; 344:e3564.

PMID: 22677795 PMC: 3370083. DOI: 10.1136/bmj.e3564.

Insulin promotes macrophage foam cell formation: potential implications in diabetes-related atherosclerosis.

Park Y, Kashyap S, A Major J, Silverstein R Lab Invest. 2012; 92(8):1171-80.

PMID: 22525426 PMC: 3407326. DOI: 10.1038/labinvest.2012.74.

References

Olefsky J, Farquhar J, Reaven G . Relationship between fasting plasma insulin level and resistance to insulin-mediated glucose uptake in normal and diabetic subjects. Diabetes. 1973; 22(7):507-13. DOI: 10.2337/diab.22.7.507. View

Fuller J, Shipley M, Rose G, Jarrett R, Keen H . Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study. Lancet. 1980; 1(8183):1373-6. DOI: 10.1016/s0140-6736(80)92651-3. View

Jarrett R, McCartney P, Keen H . The Bedford survey: ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics. Diabetologia. 1982; 22(2):79-84. DOI: 10.1007/BF00254833. View

Brand F, Abbott R, Kannel W . Diabetes, intermittent claudication, and risk of cardiovascular events. The Framingham Study. Diabetes. 1989; 38(4):504-9. DOI: 10.2337/diab.38.4.504. View

Gwinup G, Elias A . Insulin as risk factor for vascular disease. Diabetes Care. 1990; 13(5):543-5. DOI: 10.2337/diacare.13.5.543b. View

Pyorala K, Savolainen E, Kaukola S, Haapakoski J . Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 9 1/2-year follow-up of the Helsinki Policemen Study population. Acta Med Scand Suppl. 1985; 701:38-52. DOI: 10.1111/j.0954-6820.1985.tb08888.x. View

Ohlson L, Svardsudd K, Welin L, Eriksson H, Wilhelmsen L, Tibblin G . Fasting blood glucose and risk of coronary heart disease, stroke, and all-cause mortality: a 17-year follow-up study of men born in 1913. Diabet Med. 1986; 3(1):33-7. DOI: 10.1111/j.1464-5491.1986.tb00702.x. View

Welborn T, Wearne K . Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care. 1979; 2(2):154-60. DOI: 10.2337/diacare.2.2.154. View

Elmfeldt D, Wilhelmsen L, Tibblin G, Vedin J, Wilhelmsson C, Bengtsson C . Registration of myocardial infarction in the city of Göteborg, Sweden. J Chronic Dis. 1975; 28(3):173-86. DOI: 10.1016/0021-9681(75)90005-3. View

10.

Ohlson L, Larsson B, Eriksson H, Svardsudd K, Welin L, Tibblin G . Diabetes mellitus in Swedish middle-aged men. The study of men born in 1913 and 1923. Diabetologia. 1987; 30(6):386-93. DOI: 10.1007/BF00292539. View

11.

Orchard T . Is insulin atherogenic?. Diabetologia. 1988; 31(6):404-5. DOI: 10.1007/BF02341514. View

12.

Jarrett R . Is insulin atherogenic?. Diabetologia. 1988; 31(2):71-5. DOI: 10.1007/BF00395550. View

13.

Stout R . Insulin and atheroma. 20-yr perspective. Diabetes Care. 1990; 13(6):631-54. DOI: 10.2337/diacare.13.6.631. View

14.

Hanssen K, Dahl-Jorgensen K, Lauritzen T, Feldt-Rasmussen B, Deckert T . Diabetic control and microvascular complications: the near-normoglycaemic experience. Diabetologia. 1986; 29(10):677-84. DOI: 10.1007/BF00870275. View

15.

Welin L, Eriksson H, Larsson B, Ohlson L, Svardsudd K, Tibblin G . Triglycerides, a major coronary risk factor in elderly men. A study of men born in 1913. Eur Heart J. 1991; 12(6):700-4. View

16.

PANZRAM G . Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1987; 30(3):123-31. DOI: 10.1007/BF00274216. View

17.

Rosengren A, Welin L, Tsipogianni A, Wilhelmsen L . Impact of cardiovascular risk factors on coronary heart disease and mortality among middle aged diabetic men: a general population study. BMJ. 1989; 299(6708):1127-31. PMC: 1837993. DOI: 10.1136/bmj.299.6708.1127. View

18.

Toeller M, Knussmann R . Reproducibility of oral glucose tolerance tests with three different loads. Diabetologia. 1973; 9(2):102-7. DOI: 10.1007/BF01230688. View

19.

Brownlee M, Cerami A, Vlassara H . Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med. 1988; 318(20):1315-21. DOI: 10.1056/NEJM198805193182007. View

20.

Lapidus L, Bengtsson C, Blohme G, Lindquist O, Nystrom E . Blood glucose, glucose tolerance and manifest diabetes in relation to cardiovascular disease and death in women. A 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. Acta Med Scand. 1985; 218(5):455-62. DOI: 10.1111/j.0954-6820.1985.tb08874.x. View